Medtronic plc Stock

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:08 2024-05-17 pm EDT 5-day change 1st Jan Change
85.92 USD +0.33% Intraday chart for Medtronic plc +3.72% +4.30%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 32.24B Sales 2025 * 33.57B Capitalization 114B
Net income 2024 * 4.56B Net income 2025 * 5.24B EV / Sales 2024 * 4.23 x
Net Debt 2024 * 22.21B Net Debt 2025 * 21.12B EV / Sales 2025 * 4.03 x
P/E ratio 2024 *
24.5 x
P/E ratio 2025 *
21.2 x
Employees 95,000
Yield 2024 *
3.2%
Yield 2025 *
3.37%
Free-Float 99.78%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Medtronic plc

1 day+0.33%
1 week+3.72%
Current month+7.08%
1 month+8.66%
3 months+1.78%
6 months+14.93%
Current year+4.30%
More quotes
1 week
83.07
Extreme 83.065
86.17
1 month
78.78
Extreme 78.78
86.17
Current year
78.43
Extreme 78.43
89.18
1 year
68.84
Extreme 68.84
91.00
3 years
68.84
Extreme 68.84
135.89
5 years
68.84
Extreme 68.84
135.89
10 years
55.54
Extreme 55.54
135.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 15-01-25
Director of Finance/CFO 58 16-05-31
Chief Operating Officer 63 21-03-31
Members of the board TitleAgeSince
Director/Board Member 62 12-12-31
Director/Board Member 70 06-12-31
Director/Board Member 68 14-12-31
More insiders
Date Price Change Volume
24-05-17 85.92 +0.33% 8,236,275
24-05-16 85.64 +1.09% 5,506,954
24-05-15 84.72 +0.50% 6,227,356
24-05-14 84.3 +0.93% 4,053,666
24-05-13 83.52 +0.82% 4,950,890

Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT

More quotes
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
85.92 USD
Average target price
94.77 USD
Spread / Average Target
+10.31%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW